BVA junior vice president role opens for nominations
"I would encourage anyone with a passion for animal health, animal welfare, and our wonderful veterinary profession, to consider putting themselves forward to join our officer team" - BVA president, Justine Shotton.
The BVA is inviting nominations from its members for the 2022/23 BVA junior vice president (JVP) role.
Representing the BVA and the wider veterinary profession, the JVP uses their expertise to provide political advice and works closely with the Association’s CEO and policy, media and membership teams.
As with other Officer positions, the term lasts for one year, beginning in September at BVA’s Annual General Meeting. The successful applicant would then become president in September 2023, with a total commitment of three years as BVA officer and a further three years serving on BVA Council.
BVA president Justine Shotton, who was elected BVA JVP in 2020/21, said: “I would encourage anyone with a passion for animal health, animal welfare, and our wonderful veterinary profession, to consider putting themselves forward to join our officer team. There’s no denying it’s hard work, but the rewards are enormous, and we’re expertly supported by an incredible team at BVA HQ.
“The team spirit is tangible, and the team brief us on key messages and ensure that everything runs smoothly, enabling us to represent the views of our members clearly and concisely, not only to policymakers and politicians but also both local and national media.
“If you think you have what it takes to represent the views and interests of BVA members and the wider UK veterinary profession to governments, politicians, and the media; forge and maintain excellent relationships with our stakeholders, and lead on a portfolio of priority issues, then why not put yourself forward?”
Nominations remain open until Monday, 17 January 2022, with BVA veterinary surgeon members invited to nominate themselves for the role. Further details, including a nomination form, are available on the BVA website.
Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.
